299 related articles for article (PubMed ID: 24247238)
21. Loss of MEF2D expression inhibits differentiation and contributes to oncogenesis in rhabdomyosarcoma cells.
Zhang M; Truscott J; Davie J
Mol Cancer; 2013 Nov; 12(1):150. PubMed ID: 24279793
[TBL] [Abstract][Full Text] [Related]
22. Interaction between SNAI2 and MYOD enhances oncogenesis and suppresses differentiation in Fusion Negative Rhabdomyosarcoma.
Pomella S; Sreenivas P; Gryder BE; Wang L; Milewski D; Cassandri M; Baxi K; Hensch NR; Carcarino E; Song Y; Chou HC; Yohe ME; Stanton BZ; Amadio B; Caruana I; De Stefanis C; De Vito R; Locatelli F; Chen Y; Chen EY; Houghton P; Khan J; Rota R; Ignatius MS
Nat Commun; 2021 Jan; 12(1):192. PubMed ID: 33420019
[TBL] [Abstract][Full Text] [Related]
23. SNAIL is a key regulator of alveolar rhabdomyosarcoma tumor growth and differentiation through repression of MYF5 and MYOD function.
Skrzypek K; Kusienicka A; Trzyna E; Szewczyk B; Ulman A; Konieczny P; Adamus T; Badyra B; Kortylewski M; Majka M
Cell Death Dis; 2018 May; 9(6):643. PubMed ID: 29844345
[TBL] [Abstract][Full Text] [Related]
24. Global DNA methylation profiling uncovers distinct methylation patterns of protocadherin alpha4 in metastatic and non-metastatic rhabdomyosarcoma.
Tombolan L; Poli E; Martini P; Zin A; Millino C; Pacchioni B; Celegato B; Bisogno G; Romualdi C; Rosolen A; Lanfranchi G
BMC Cancer; 2016 Nov; 16(1):886. PubMed ID: 27842508
[TBL] [Abstract][Full Text] [Related]
25. miR-30e acts as a tumor suppressor in hepatocellular carcinoma partly via JAK1/STAT3 pathway.
Mao J; Hu X; Pang P; Zhou B; Li D; Shan H
Oncol Rep; 2017 Jul; 38(1):393-401. PubMed ID: 28560434
[TBL] [Abstract][Full Text] [Related]
26. Distinct roles for miR-1 and miR-133a in the proliferation and differentiation of rhabdomyosarcoma cells.
Rao PK; Missiaglia E; Shields L; Hyde G; Yuan B; Shepherd CJ; Shipley J; Lodish HF
FASEB J; 2010 Sep; 24(9):3427-37. PubMed ID: 20466878
[TBL] [Abstract][Full Text] [Related]
27. Progression and Differentiation of Alveolar Rhabdomyosarcoma Is Regulated by PAX7 Transcription Factor-Significance of Tumor Subclones.
Skrzypek K; Adamek G; Kot M; Badyra B; Majka M
Cells; 2021 Jul; 10(8):. PubMed ID: 34440639
[TBL] [Abstract][Full Text] [Related]
28. PAX3-FOXO1 drives miR-486-5p and represses miR-221 contributing to pathogenesis of alveolar rhabdomyosarcoma.
Hanna JA; Garcia MR; Lardennois A; Leavey PJ; Maglic D; Fagnan A; Go JC; Roach J; Wang YD; Finkelstein D; Hatley ME
Oncogene; 2018 Apr; 37(15):1991-2007. PubMed ID: 29367756
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of the interferon-gamma/signal transducers and activators of transcription (STAT) pathway by hypermethylation at a STAT-binding site in the p21WAF1 promoter region.
Chen B; He L; Savell VH; Jenkins JJ; Parham DM
Cancer Res; 2000 Jun; 60(12):3290-8. PubMed ID: 10866323
[TBL] [Abstract][Full Text] [Related]
30. RBPJ is a novel target for rhabdomyosarcoma therapy.
Nagao H; Setoguchi T; Kitamoto S; Ishidou Y; Nagano S; Yokouchi M; Abematsu M; Kawabata N; Maeda S; Yonezawa S; Komiya S
PLoS One; 2012; 7(7):e39268. PubMed ID: 22792167
[TBL] [Abstract][Full Text] [Related]
31. TBX2 blocks myogenesis and promotes proliferation in rhabdomyosarcoma cells.
Zhu B; Zhang M; Byrum SD; Tackett AJ; Davie JK
Int J Cancer; 2014 Aug; 135(4):785-97. PubMed ID: 24470334
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of rhabdomyosarcoma cell and tumor growth by targeting specificity protein (Sp) transcription factors.
Chadalapaka G; Jutooru I; Sreevalsan S; Pathi S; Kim K; Chen C; Crose L; Linardic C; Safe S
Int J Cancer; 2013 Feb; 132(4):795-806. PubMed ID: 22815231
[TBL] [Abstract][Full Text] [Related]
33. JAK/STAT signaling and human in vitro myogenesis.
Trenerry MK; Della Gatta PA; Cameron-Smith D
BMC Physiol; 2011 Mar; 11():6. PubMed ID: 21388555
[TBL] [Abstract][Full Text] [Related]
34. Epigenetically upregulated GEFT-derived invasion and metastasis of rhabdomyosarcoma via epithelial mesenchymal transition promoted by the Rac1/Cdc42-PAK signalling pathway.
Liu C; Zhang L; Cui W; Du J; Li Z; Pang Y; Liu Q; Shang H; Meng L; Li W; Song L; Wang P; Xie Y; Wang Y; Liu Y; Hu J; Zhang W; Li F
EBioMedicine; 2019 Dec; 50():122-134. PubMed ID: 31761617
[TBL] [Abstract][Full Text] [Related]
35. MicroRNA-137 is downregulated in glioblastoma and inhibits the stemness of glioma stem cells by targeting RTVP-1.
Bier A; Giladi N; Kronfeld N; Lee HK; Cazacu S; Finniss S; Xiang C; Poisson L; deCarvalho AC; Slavin S; Jacoby E; Yalon M; Toren A; Mikkelsen T; Brodie C
Oncotarget; 2013 May; 4(5):665-76. PubMed ID: 23714687
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activation of MET signaling impairs myogenic differentiation of rhabdomyosarcoma and promotes its development and progression.
Skrzypek K; Kusienicka A; Szewczyk B; Adamus T; Lukasiewicz E; Miekus K; Majka M
Oncotarget; 2015 Oct; 6(31):31378-98. PubMed ID: 26384300
[TBL] [Abstract][Full Text] [Related]
37. SIX1 reprograms myogenic transcription factors to maintain the rhabdomyosarcoma undifferentiated state.
Hsu JY; Danis EP; Nance S; O'Brien JH; Gustafson AL; Wessells VM; Goodspeed AE; Talbot JC; Amacher SL; Jedlicka P; Black JC; Costello JC; Durbin AD; Artinger KB; Ford HL
Cell Rep; 2022 Feb; 38(5):110323. PubMed ID: 35108532
[TBL] [Abstract][Full Text] [Related]
38. Berberine suppresses bladder cancer cell proliferation by inhibiting JAK1-STAT3 signaling via upregulation of miR-17-5p.
Xia Y; Chen S; Cui J; Wang Y; Liu X; Shen Y; Gong L; Jiang X; Wang W; Zhu Y; Sun S; Li J; Zou Y; Shi B
Biochem Pharmacol; 2021 Jun; 188():114575. PubMed ID: 33887260
[TBL] [Abstract][Full Text] [Related]
39. MiR-155 regulates lymphoma cell proliferation and apoptosis through targeting SOCS3/JAK-STAT3 signaling pathway.
Li XD; Li XM; Gu JW; Sun XC
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5153-5159. PubMed ID: 29228427
[TBL] [Abstract][Full Text] [Related]
40. Deep Sequencing Reveals a Novel miR-22 Regulatory Network with Therapeutic Potential in Rhabdomyosarcoma.
Bersani F; Lingua MF; Morena D; Foglizzo V; Miretti S; Lanzetti L; Carrà G; Morotti A; Ala U; Provero P; Chiarle R; Singer S; Ladanyi M; Tuschl T; Ponzetto C; Taulli R
Cancer Res; 2016 Oct; 76(20):6095-6106. PubMed ID: 27569217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
